Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. (Q45205104)
Jump to navigation
Jump to search
scientific article published in December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. |
scientific article published in December 2004 |
Statements
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (English)
Bradley A Schiff
Andrea B McMurphy
Samar A Jasser
Maher N Younes
Dao Doan
Orhan G Yigitbasi
Seungwon Kim
Ge Zhou
Benjamin N Bekele
F Christopher Holsinger
Sai-Ching Yeung
Adel K El-Naggar